Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01027767 · ClinicalTrials.gov registry record
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 23
- Enrollment target
NCT01027767: Completed study, sponsored by Mayo Clinic.
NCT01027767 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01027767 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The investigators hope to prove that radiation and surgical scarring does not result in changes that affect the MBI pattern 6-12 months after completion of treatment.
Interventions
- DEVICE Molecular Breast Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01027767
The ClinicalTrials.gov registry entry for NCT01027767 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular Breast Imaging is the first listed.
NCT01027767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01027767 about?
NCT01027767 is a clinical study titled "Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging". The investigators hope to prove that radiation and surgical scarring does not result in changes that affect the MBI pattern 6-12 months after completion of treatment.
What is the current status of trial NCT01027767?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2009-05. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01027767?
The interventions under investigation include: Molecular Breast Imaging (DEVICE).
Who is sponsoring clinical trial NCT01027767?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.